Advertisement
Screener

Clovis Oncology, Inc. Form PRE 14A: Preliminary proxy statement

Clovis Oncology, Inc. Form PRE 14A: Preliminary proxy statement

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2022-04-15: Form PRE 14A; Period of report 2022-06-09; Description PRE 14A; Document d298135dpre14a.htm.
  • 2021-04-16: Form PRE 14A; Period of report 2021-06-10; Description PRE 14A; Document d277536dpre14a.htm.
  • 2019-04-15: Form PRE 14A; Period of report 2019-06-06; Description PRE 14A; Document d668722dpre14a.htm.
FiledFormPeriod of reportDescriptionDocument
2022-04-15PRE 14A2022-06-09PRE 14Ad298135dpre14a.htm
2021-04-16PRE 14A2021-06-10PRE 14Ad277536dpre14a.htm
2019-04-15PRE 14A2019-06-06PRE 14Ad668722dpre14a.htm